Company Filing History:
6 out of 1,036 
3 out of 1,209 
1 out of 60 
Years Active: 2021-2025
Title: The Innovative Contributions of David J Dowling
Introduction
David J Dowling is a prominent inventor based in Brighton, MA (US), known for his significant contributions to the field of immunology. With a total of six patents to his name, Dowling has focused on enhancing human immune responses through innovative compounds and methods.
Latest Patents
Among his latest patents is the use of toll-like receptor 2 (TLR-2) agonists for modulating the human immune response. This patent details the application of TLR2 agonists, including thiophenes, imidazoles, and phenyl-containing compounds, which serve as enhancers of immune responses. These compounds are particularly useful in treating and preventing various diseases, including proliferative, inflammatory, autoimmune, infectious, and chronic diseases. Another notable patent involves a composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine, aimed at enhancing human immune response and serving as adjuvants in vaccines.
Career Highlights
David J Dowling has worked with esteemed organizations such as Children's Medical Center Corporation and Dana-Farber Cancer Institute. His work in these institutions has allowed him to advance his research and contribute to significant developments in immunology.
Collaborations
Dowling has collaborated with notable colleagues, including Ofer Levy and Francesco Borriello, further enhancing the impact of his research through shared expertise and innovative ideas.
Conclusion
David J Dowling's work exemplifies the intersection of innovation and healthcare, particularly in the realm of immunology. His patents and collaborations reflect a commitment to advancing medical science and improving human health through innovative solutions.